Might be the way the diabetes drug interfered with the sugar level, unintentionally starving or weakening the cancer cells. Just my 2 cents worth of thought.Anyway, here's an article on yervoy (ipilimumab) which might be encouraging for PRR holders.
http://medcitynews.com/2013/09/immunotherapy-skin-cancer-treatments-melanoma-breakthrough/
I am more positive now at what Dr. Goh has to deliver next week.
endpoints for immunotherapy, page-7
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.0¢ | 30.5¢ | $634.7K | 2.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 193273 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 28352 | 10 |
View Market Depth
| Last trade - 15.28pm 13/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |